These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35973741)

  • 1. Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy.
    Gatta LA; Weber JM; Gilner JB; Lee PS; Grotegut CA; Herbert KA; Bashir M; Pieper CF; Ronald J; Pabon-Ramos W; Habib AS; Strickland KC; Secord AA; James AH
    Am J Perinatol; 2022 Oct; 29(14):1503-1513. PubMed ID: 35973741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: A case series.
    Gatta LA; Lee PS; Gilner JB; Weber JM; Adkins L; Salinaro JR; Habib AS; Pabon-Ramos W; Strickland KC; Ronald J; Erkanli A; Mehdiratta JE; Grotegut CA; Secord AA
    Gynecol Oncol Rep; 2021 Aug; 37():100833. PubMed ID: 34368412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine Artery Embolization following Cesarean Delivery but prior to Hysterectomy in the Management of Patients with Invasive Placenta.
    Wang M; Ballah D; Wade A; Taylor AG; Rizzuto G; Li B; Lucero J; Chen LM; Kohi MP
    J Vasc Interv Radiol; 2019 May; 30(5):687-691. PubMed ID: 30922797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cesarean delivery with and without uterine artery embolization for the management of placenta accreta spectrum disorder-A comparative study.
    Mohr-Sasson A; Hochman R; Anteby M; Spira M; Castel E; Hendler I; Mazaki-Tovi S; Sivan E
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1374-1380. PubMed ID: 32282925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
    Sentilhes L; Seco A; Azria E; Beucher G; Bonnet MP; Branger B; Carbillon L; Chiesa C; Crenn-Hebert C; Dreyfus M; Dupont C; Fresson J; Huissoud C; Langer B; Morel O; Patrier S; Perrotin F; Raynal P; Rozenberg P; Rudigoz RC; Vendittelli F; Winer N; Deneux-Tharaux C; Kayem G;
    Am J Obstet Gynecol; 2022 Jun; 226(6):839.e1-839.e24. PubMed ID: 34914894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Ramsey PS; Greebon LJ; Salazar E; McCann GA; Byrne JJ
    Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():32-35. PubMed ID: 38100939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypocalcemia during surgery for placenta accreta spectrum: The case for empiric replacement.
    Erfani H; Shamshirsaz AA; Fox KA; Rezaei A; Hui SR; Shamshirsaz AA; Nassr AA; Salmanian B; Espinoza J; Teruya J; Belfort MA
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1326-1331. PubMed ID: 31034579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis.
    Pan S; Han M; Zhai T; Han Y; Lu Y; Huang S; Zuo Q; Jiang Z; Ge Z
    BMC Pregnancy Childbirth; 2024 Jul; 24(1):463. PubMed ID: 38969992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss.
    Seoud MA; Nasr R; Berjawi GA; Zaatari GS; Seoud TM; Shatila AS; Mirza FG
    J Neonatal Perinatal Med; 2017; 10(1):9-15. PubMed ID: 28304318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to reduce blood loss in patients with placenta accreta spectrum disorder.
    Turan OM; Shannon A; Asoglu MR; Goetzinger KR
    J Matern Fetal Neonatal Med; 2021 Jul; 34(13):2061-2070. PubMed ID: 31455134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial.
    Nieto-Calvache ÁJ; Aryananda RA; Palacios-Jaraquemada JM; Cininta N; Grace A; Benavides-Calvache JP; Campos CI; Messa-Bryon A; Vallecilla L; Sarria D; Galindo JS; Galindo-Velasco V; Rivera-Torres LF; Burgos-Luna JM; Bhide A
    Am J Obstet Gynecol MFM; 2024 Jun; 6(6):101333. PubMed ID: 38458362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum.
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Am J Obstet Gynecol; 2023 Jul; 229(1):61.e1-61.e7. PubMed ID: 36965865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Blood Cell Transfusion in Patients With Placenta Accreta Spectrum: A Systematic Review and Meta-analysis.
    Miller SE; Leonard SA; Meza PK; Ku S; Ren LY; Lyell DJ; Sultan P; Butwick A
    Obstet Gynecol; 2023 Jan; 141(1):49-58. PubMed ID: 36701609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy in surgical management of placenta accreta spectrum.
    Shamshirsaz AA; Fox KA; Erfani H; Clark SL; Hui SK; Shamshirsaz AA; Rezaei A; Nassr AA; Lake YN; Teruya J; Belfort MA
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():126-130. PubMed ID: 31029971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.